Augmentum Fintech (LON:AUGM) is a new London-listed investment company that was created to profit from opportunities in the UK and European Fintech sector. It will concentrate on businesses with innovative technologies that have the power to change the way we conduct our financial affairs and will distribute 50% of the realised gains made each year. AUGM…
Shares in commercial biotech company Allergy Therapeutics (AGY) had shot up by 7.76% to 26.40p at 1320 BST after the company announced positive top line results from phase II trials for a treatment for glass allergies.
I was a bit surprised by a story in yesterday’s Sunday Telegraph to the effect that the total assets falling to be distributed by the administrators of Beaufort Securities was of the order of £500 million to £850 million but that the fee charged by PwC for this would be of the order of £100…
Italian gaming regulators have approved FTSE 250 gaming technology outfit Playtech’s (PTEC) €846 million acquisition of Snaitech.
Shares in drug maker AstraZeneca (AZN) rose had risen by 2.52% to 5,373p at 1100 BST after the US Food and Drug Administration approved Lokelma, which is designed to treat high blood potassium levels.
Far-sighted investors are assessing how they can position themselves to capitalise on any opening-up of the North Korean economy. I’ve stumbled across this Main Market listed company that appears to be the closest thing to a UK-listed play on this opportunity… Donald Trump is scheduled to meet Kim Jong Un in a historic summit in…
FTSE 100 miner Glencore (GLEN) has seen its shares tumble 4.56% to 380.60p this afternoon on the back of news that it will be investigated by the Serious Fraud Office.
Carpetright (CPR) has announced plans to raise net proceeds of £60 million via a placing of new shares. Roughly a third of these funds will be used to cover the costs of its company voluntary arrangement and repay outstanding short term debts while the remainder will satisfy the capital expenditure requirements of the firm’s Revised Business Plan.
Pharma giant AstraZeneca (AZN) struggled during the first quarter with sales and earnings falling, Investment in new products, and a faster than anticipated decay of Crestor sales in Europe and Japan.
At the last general election, I did not bother to vote since the notion of the Conservatives being upstaged in Kensington struck me as ridiculous. But, unbeknowst to me, the boundaries had been changed. So, Labour won by twenty votes – I was not alone in my idleness. The result is one Emma Jane Coad.…
